This site is intended for health professionals only
Monday 26 September 2016 Instagram
Share |

Risks and benefits of tiotropium in the treatment of COPD

Risks and benefits of tiotropium in the treatment of COPD

Respiratory

Peter Burrill
BPharm(Hons) MRPharmS DipPresSci FCPP FFPMM
Specialist Pharmaceutical Adviser for Public Health
Derbyshire County Primary Care Trust

It has been suggested that the use of inhaled anticholinergic drugs increases the risk of cardiovascular events in chronic obstructive pulmonary disease. Peter Burrill takes a look at the results of the UPLIFT trial, and the implications for treatment

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?